by MM360 Staff | Jun 10, 2021 | Twitter
Big thank you 🙌 to @SurbhiSidanaMD for summarizing and putting into perspective the exciting new data presented at #ASCO21 on #CARTcells and T-cell engagers for relapsed #myeloma #mmsm pic.twitter.com/f5oNHeeTLM— Multiple Myeloma Hub (@MM_Hub) June 8, 2021
by MM360 Staff | Jun 10, 2021 | Twitter
@SurbhiSidanaMD #ASCO21 What about non-BCMA novel therapies? #mmsm pic.twitter.com/HUAWHWjzSY— Multiple Myeloma Hub (@MM_Hub) June 8, 2021
by MM360 Staff | Jun 10, 2021 | Twitter
#ASCO21 Tuesday 8AM EST ➡️Plasma Cell Dyscrasia Session ➡️Please join me and my colleague @PLMcCarthyMD for fantastic presentations on #myeloma with @profBigG @Ccostello7 @szusmani @NBahlis @DoctorAKrishnan @BerdejaJesus @SurbhiSidanaMD https://t.co/Iny6YvtqUc—...
by MM360 Staff | Jun 10, 2021 | Twitter
@ASCO presented by @MyMKaiser ➡️ Dara-CVRD for Ultra High Risk #myeloma and Plasmacell leukemia induces deep remissions ➡️but still with shorter PFS #ASCO21 #mmsm pic.twitter.com/mkkFPNwpdi— Suzanne Lentzsch, MD, PhD (@SLentzsch) June 8, 2021
by MM360 Staff | Jun 10, 2021 | Twitter
Some of the data presented today @ASCO will shape the future treatment of Myeloma! Will this GPRC5D TCE the rescue after BCMA treatment in #Myeloma? Congrats @BerdejaJesus on a great presentation 👏 https://t.co/i1mKY03EJS— Suzanne Lentzsch, MD, PhD (@SLentzsch) June...
